Alta Sciences

JUNE 9, 2023

Accelerating Global Drug Development Timelines With Ethnobridging rmaloney Mon, 06/12/2023 - 16:07 HTML Safe Strategy to Save Time and Money Avoid repeating Phase I studies for drugs intended for the Asian market. Download your copy today. In this complimentary webinar , Mel B.

Drug Development 40

Drug Development Clinical Trials Biosimilars Pharmacokinetics 40

Drug Channels

MARCH 14, 2023

Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Analyzes Impact of Inflation Reduction Act on U.S. Read on for some additional details.

Pharmacy 86

Pharmacy Drugs Marketing Biosimilars 86

Drug Channels

NOVEMBER 8, 2021

Year after year, the life science industry marks Informa Connect’s Trade and Channel Strategies as the “go-to” event for trade, channel, market access, account strategy and brand professionals. The full agenda for this year’s Trade and Channel Strategies conference is available now! Meet The Expert Faculty.

Specialty Pharmacies 69

Specialty Pharmacies Pharmacy Biosimilars Marketing 69

Drug Channels

FEBRUARY 21, 2023

Those who preorder will receive a download link before March 14. CLICK HERE to download a free pre-publication overview (including key industry trends, the Table of Contents, and a List of Exhibits). Download a free report overview for more details on the new sections and content.

Pharmacy 75

Pharmacy Specialty Pharmacies Licensing Licensing 75

The Pharma Data

NOVEMBER 10, 2020

View original content to download multimedia: [link]. The company has also entered into strategic collaborations with Eli Lilly and Company, Roche, Adimab, Incyte, MD Anderson Cancer Center, Hanmi and other international partners. For more information, please visit: www.innoventbio.com. SOURCE Innovent Biologics, Inc. Source link.

Biosimilars 52

Biosimilars Clinical Trials International Clinical Development 52

The Pharma Data

SEPTEMBER 17, 2020

Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Source link.

Therapies 52

Therapies Production Government Disease 52

The Pharma Data

SEPTEMBER 16, 2020

The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. SOURCE Amgen. Source link.

Clinical Trials 52

Clinical Trials Production Trials Government 52

The Pharma Data

SEPTEMBER 20, 2020

The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. 2019;38:2953-2966. 8 Canon J, et al.

Clinical Trials 52

Clinical Trials Production Trials Government 52

The Pharma Data

AUGUST 13, 2020

Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. SOURCE Amgen.

Production 52

Production Government Regulations Marketing 52

The Pharma Data

AUGUST 13, 2020

” Consummation of the Exchange Offers is subject to the satisfaction of certain conditions, including the absence of certain adverse legal and market developments. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities.

Production 52

Production Government Marketing Regulations 52

The Pharma Data

NOVEMBER 9, 2020

The length of time that it takes for Amgen to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and Amgen expects similar variability in the future. Amgen may not be able to access the capital and credit markets on terms that are favorable to it, or at all. J Allergy Clin Immunol.

Trials 52

Trials Production Clinical Trials Government 52

The Pharma Data

DECEMBER 21, 2020

The length of time that it takes for Amgen to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and Amgen expects similar variability in the future. Amgen may not be able to access the capital and credit markets on terms that are favorable to it, or at all. Available at: [link].

Trials 40

Trials Production Clinical Trials Therapies 40